Voloridge Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.24M | Buy |
333,923
+268,813
| +413% | +$7.44M | 0.03% | 568 |
|
2025
Q1 | $1.45M | Sell |
65,110
-75,768
| -54% | -$1.68M | 0.01% | 1004 |
|
2024
Q4 | $2.79M | Sell |
140,878
-49,108
| -26% | -$971K | 0.01% | 897 |
|
2024
Q3 | $4.75M | Buy |
189,986
+164,200
| +637% | +$4.1M | 0.02% | 789 |
|
2024
Q2 | $481K | Sell |
25,786
-8,276
| -24% | -$155K | ﹤0.01% | 1124 |
|
2024
Q1 | $672K | Buy |
+34,062
| New | +$672K | ﹤0.01% | 1022 |
|
2020
Q3 | – | Sell |
-12,036
| Closed | -$307K | – | 1369 |
|
2020
Q2 | $307K | Buy |
+12,036
| New | +$307K | ﹤0.01% | 1136 |
|